2022 International Conference on Connected Systems &Amp; Intelligence (CSI) 2022
DOI: 10.1109/csi54720.2022.9924058
|View full text |Cite
|
Sign up to set email alerts
|

Deep Learning Approaches for Early Detection of Alzheimer's Disease using MRI Neuroimaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Early detection is crucial in order to receive appropriate treatment from specialist's Magnetic resonance imaging (MRI) is a non-intrusive approach used to diagnose and observe brain tissue in individuals with Alzheimer's. MRI results of Alzheimer's patients often reveal abnormalities in the cortical and periventricular regions, hippocampal atrophy and amygdala changes in the subcortical region which are early indicators of dementia [6][7][8][9][10].AD has a prolonged preclinical phase, which begins around 10 to 16 years at the least before appearance of noticeable symptoms. The brains of older individuals are examined for clinical diagnosis with no cognitive impairment (CN) or mild cognitive impairment (MCI), similar pathological symptoms to those with confirmed AD are often kept under observation suggesting presence of an asymptomatic phase of AD that varies among the elderly population.…”
Section: Introductionmentioning
confidence: 99%
“…Early detection is crucial in order to receive appropriate treatment from specialist's Magnetic resonance imaging (MRI) is a non-intrusive approach used to diagnose and observe brain tissue in individuals with Alzheimer's. MRI results of Alzheimer's patients often reveal abnormalities in the cortical and periventricular regions, hippocampal atrophy and amygdala changes in the subcortical region which are early indicators of dementia [6][7][8][9][10].AD has a prolonged preclinical phase, which begins around 10 to 16 years at the least before appearance of noticeable symptoms. The brains of older individuals are examined for clinical diagnosis with no cognitive impairment (CN) or mild cognitive impairment (MCI), similar pathological symptoms to those with confirmed AD are often kept under observation suggesting presence of an asymptomatic phase of AD that varies among the elderly population.…”
Section: Introductionmentioning
confidence: 99%